Clinical Trial Update: Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial updating safety and efficacy of TVI-Brain-1 for recurrent grade IV glioma; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Glioblastoma
• Glioma

Drugs mentioned

• TVI-Brain-1

Snippet

Sponsor: TVAX Biomedical | Conditions: Grade IV Glioma, Grade IV Astrocytoma | Phase 2 | Status: COMPLETED | Results posted: 2023-06-29